The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction

NACompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions
Induced; Birth
Interventions
DRUG

Continuation or discontinuation of oxytocin during the active first stage of labor (≥6 cm dilation).

"At the intervention site (Foothills Medical Centre), for participants who consent to being part of the trial, once a patient is found to be \>= 6 cm dilation, the study medication will be initiated. Pharmacy will make up identical vials of oxytocin or saline, which will be numbered according to the random allocation sequence created by the study statistician.~The intervention will be continued until delivery unless contractions decrease to less than 2 in 10 minutes or if no further cervical dilation is noted 4 hours after discontinuation."

Trial Locations (1)

T2N 2T9

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT05037617 - The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction | Biotech Hunter | Biotech Hunter